Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

XKR7 Inhibitors

XKR7 inhibitors are chemical compounds designed to target and inhibit the activity of the XKR7 protein, a member of the XK-related (XKR) family, which is involved in regulating cellular membrane dynamics. XKR7, like other proteins in the XKR family, is believed to play a role in processes such as phospholipid translocation and membrane reorganization, which are essential for maintaining the structural integrity and function of cellular membranes. XKR7 is likely involved in regulating the movement of phospholipids between the inner and outer layers of the lipid bilayer, an important process in cell membrane maintenance. This protein is also thought to contribute to cellular mechanisms related to membrane asymmetry and remodeling, which are critical during cellular activities such as cell division, apoptosis, and response to environmental stressors.

Inhibitors of XKR7 work by binding to key functional or regulatory sites on the protein, preventing it from executing its role in membrane dynamics and phospholipid translocation. This inhibition can disrupt the normal movement of phospholipids, which may alter membrane fluidity and asymmetry, affecting processes like signal transduction, apoptosis regulation, and other membrane-related cellular activities. Inhibiting XKR7 could also influence how cells respond to external cues that require membrane changes, such as during cell migration or cellular stress responses. The structural and functional study of XKR7 inhibitors helps reveal their impact on the delicate balance of membrane organization and the broader cellular processes that depend on precise membrane function. Understanding these interactions is crucial for exploring how XKR7 regulates the dynamic nature of cellular membranes and how its inhibition affects overall cellular physiology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

Statins may indirectly influence XKR7 by altering cholesterol synthesis and membrane lipid composition, potentially affecting XKR7's function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, a PI3K/Akt/mTOR inhibitor, could impact XKR7 indirectly through cellular signaling pathways related to membrane dynamics and protein trafficking.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine might indirectly affect XKR7 by modulating calcium signaling, which can be relevant for membrane-associated proteins.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may indirectly affect XKR7 through its role in chromatin remodeling and gene expression, potentially impacting XKR7's expression or function.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitors like Bortezomib could indirectly influence XKR7 by modulating protein degradation pathways.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine, an autophagy modulator, could have indirect implications for XKR7 through its role in cellular degradation processes.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082, an NF-κB pathway inhibitor, may indirectly impact XKR7 by affecting cellular signaling involved in inflammation and stress responses.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Ruxolitinib might indirectly impact XKR7 by modulating JAK/STAT signaling pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126, an inhibitor of the ERK/MAPK pathway, might indirectly affect XKR7 by influencing cell differentiation and growth pathways.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

17-AAG, an HSP90 inhibitor, could affect XKR7 indirectly by impacting protein folding and stability.